文献速递功能神经外科

重新审视再次微血管减压术治疗三叉神经痛的疗效

Revisiting the Efficacy of Redo Microvascular Decompression for Trigeminal Neuralgia.
PubMed 文献 · World Neurosurg · 2024-03-27

该回顾性研究分析103例初次三叉神经痛患者再次微血管减压术,并与同期348例初次微血管减压术患者比较。再次手术组即刻缓解率94.2%,平均随访17.4±4.4个月长期缓解率89.3%,两组即刻缓解率、长期缓解率及并发症无显著差异。作者认为再次微血管减压术与初次手术同样有效且安全。

要点

  • 再次微血管减压术即刻缓解率94.2%,平均随访17.4±4.4个月长期缓解率89.3%。
  • 再次手术组与初次手术组在即刻缓解率、长期缓解率及并发症方面无显著差异。
  • 10例无明显压迫者接受神经梳理,均即刻完全缓解,仅1例术后9个月复发。

核心结论

  • 再次微血管减压术治疗三叉神经痛与初次手术同样有效且安全,强调仔细分离和充分减压。
  • 对于无明显压迫的患者,神经梳理被证明是有效的补充选择。

研究设计与样本

  • 回顾性分析2020年1月至2022年12月在本中心接受再次微血管减压术的103例原发性三叉神经痛患者,并与同期接受初次微血管减压术的348例患者进行比较。

主要发现

  • 再次手术中观察到蛛网膜粘连(80.6%)、Teflon粘连伴或不伴肉芽肿(86.4%)以及残留血管压迫(36.9%)。
  • 再次手术后即刻缓解率为94.2%,平均随访17.4±4.4个月长期缓解率为89.3%。
  • 术后并发症包括3例持续性感觉异常,听力下降、脑脊液漏和面瘫各1例。
  • 10例无明显压迫者接受神经梳理,均即刻完全缓解,仅1例术后9个月复发。
  • 与初次手术组相比,再次手术组平均年龄更大、病程更长、手术时间更长(P < 0.05),但两组即刻缓解率、长期缓解率及并发症无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microvascular decompression (MVD) is an effective nondestructive neurosurgical procedure for trigeminal neuralgia (TN). However, some patients may undergo surgery failure or experience pain recurrence, sparking debates on the need for reoperation. METHODS: We conducted a retrospective analysis of 103 cases of patients with primary TN who underwent redo MVD at our center between January 2020 and December 2022. Comparative prognostic assessments were performed by comparing these cases against a cohort of 348 patients who underwent primary MVD during the same study period. RESULTS: During the redo MVD cases, arachnoid membranes adhesions (80.6%) and Teflon adhesions with/without granuloma (86.4%) as well as remaining vascular compression (36.9%) were observed. After the reoperation, an immediate relief rate of 94.2% was observed. During a mean follow-up period of 17.4 ± 4.4 months, a long-term relief rate of 89.3% was achieved. Postoperative complications included 3 cases of persistent paresthesia, 1 case each of hearing loss, cerebrospinal fluid leak, and facial palsy. Ten cases without evident compression received nerve combing and all experienced immediate complete relief, with only 1 patient experiencing recurrence 9 months after surgery. Compared to the primary MVD group, the reoperation group had a higher average age, longer disease duration, and operating time (P < 0.05). However, there were no significant differences in immediate relief rate, long-term relief rate, or complications between the 2 groups. The main cause of persistent symptom was inadequate decompression, such as missing the offending vessel; while the recurrent was primarily due to Teflon adhesion or granuloma formation. CONCLUSIONS: The redo MVD for TN is equally efficacious and safe compared to the primary procedure, with an emphasis on meticulous dissection and thorough decompression. Additionally, nerve combing proves to be an effective supplementary option for patients without obvious compression.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Zhao H, Tang Y, et al. Revisiting the Efficacy of Redo Microvascular Decompression for Trigeminal Neuralgia. World Neurosurg. 2024. PMID: 38552788. doi:10.1016/j.wneu.2024.03.131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。